C57BL/6JCya-Fgfr1em1/Cya
Common Name
Fgfr1-KO
Product ID
S-KO-02049
Backgroud
C57BL/6JCya
Strain ID
KOCMP-14182-Fgfr1-B6J-VA
Status
When using this mouse strain in a publication, please cite “Fgfr1-KO Mouse (Catalog S-KO-02049) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
Basic Information
Strain Name
Fgfr1-KO
Strain ID
KOCMP-14182-Fgfr1-B6J-VA
Gene Name
Product ID
S-KO-02049
Gene Alias
FLG, Fr1, MFR, Eask, Hspy, Flt-2, c-fgr, FGFR-I, Fgfr-1, bFGF-R-1
Background
C57BL/6JCya
NCBI ID
Modification
Conventional knockout
Chromosome
Chr 8 (Mouse)
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Transcript ID
ENSMUST00000084027
NCBI Transcript ID
NM_010206
Target Region
Exon 4~5
Size of Effective Region
~1.9 kb
Overview of Gene Research
Fgfr1, or fibroblast growth factor receptor 1, is a transmembrane cytokine receptor crucial for early human embryo development, involved in gastrulation, organ specification, and tissue patterning. It is associated with multiple biological pathways, and its activity is mediated through phospholipase-C-gamma (PLCγ) and activation of nuclear factor-κB (NF-κB) in macrophages [1]. It also plays a role in regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells, thus governing iron homeostasis [3].
In atherosclerosis, deletion of myeloid-expressed Fgfr1 in Apoe-/-mice reduces atherosclerotic lesions and lipid accumulations, indicating that macrophage-derived Fgfr1 drives atherosclerosis via the PLCγ-mediated activation of the NF-κB inflammatory signalling pathway [1]. In prostate cancer, deletion of Fgfr1 in DU145 cells decreases the labile iron pool (LIP), suggesting its role in cancer progression [3].
In conclusion, Fgfr1 is essential for embryo development and tissue patterning. Model-based research, especially gene knockout in mice, has revealed its role in diseases like atherosclerosis and prostate cancer. Understanding Fgfr1 function provides potential therapeutic targets for these and other associated diseases, such as Kallmann syndrome, congenital scoliosis, and tooth agenesis as identified in various studies [2,4,5].
References:
1. Wang, Lintao, Luo, Wu, Zhang, Suya, Xu, Biao, Liang, Guang. . Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway. In Cardiovascular research, 120, 1385-1399. doi:10.1093/cvr/cvae131. https://pubmed.ncbi.nlm.nih.gov/38842387/
2. Villanueva, C, de Roux, N. 2010. FGFR1 mutations in Kallmann syndrome. In Frontiers of hormone research, 39, 51-61. doi:10.1159/000312693. https://pubmed.ncbi.nlm.nih.gov/20389085/
3. Lin, Hui, Lin, Shuaijun, Shi, Liuhong, Pan, Xuebo, Wang, Cong. 2024. FGFR1 governs iron homeostasis via regulating intracellular protein degradation pathways of IRP2 in prostate cancer cells. In Communications biology, 7, 1011. doi:10.1038/s42003-024-06704-6. https://pubmed.ncbi.nlm.nih.gov/39154074/
4. Wang, Shengru, Chai, Xiran, Yan, Zihui, Zhang, Terry Jianguo, Wu, Nan. 2021. Novel FGFR1 Variants Are Associated with Congenital Scoliosis. In Genes, 12, . doi:10.3390/genes12081126. https://pubmed.ncbi.nlm.nih.gov/34440300/
5. Yao, Siyue, Zhou, Xi, Gu, Min, Ma, Lan, Pan, Yongchu. 2023. FGFR1 variants contributed to families with tooth agenesis. In Human genomics, 17, 93. doi:10.1186/s40246-023-00539-8. https://pubmed.ncbi.nlm.nih.gov/37833774/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
